Susquehanna International Group
VNRX icon

Susquehanna International Group’s VolitionRx Ltd VNRX Stock Holding History

Susquehanna International Group’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-955
Closed -$36.5K – 13233
2023
Q1 		$36.5K Sell
955
-375
-28% -$15.7K ﹤0.01% 11833
2022
Q4 		$64.6K Sell
1,330
-310
-19% -$12K ﹤0.01% 11252
2022
Q3 		$45K Sell
1,640
-465
-22% -$17.6K ﹤0.01% 12273
2022
Q2 		$86K Buy
2,105
+430
+26% +$21.7K ﹤0.01% 11612
2022
Q1 		$101K Sell
1,675
-290
-15% -$16.4K ﹤0.01% 11910
2021
Q4 		$123K Sell
1,965
-55
-3% -$3.75K ﹤0.01% 11987
2021
Q3 		$125K Buy
2,020
+450
+29% +$28.5K ﹤0.01% 11922
2021
Q2 		$103K Buy
+1,570
New +$106K ﹤0.01% 12085

Other funds holding VNRX

LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LM
Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return

Susquehanna International Group's VNRX Position: Q1 2026 in Review

Susquehanna International Group sold out of VolitionRx Ltd (VNRX) in Q1 2026, closing a stake of 2,842 shares — an estimated $14.5K sold.

Susquehanna International Group first reported a position in VNRX in Q4 2018 and held it in 17 quarters. The position peaked at $249K in Q1 2021. 31 funds tracked by Wall St. Rank hold VNRX as of Q1 2026.

  • Susquehanna International Group reported no remaining VolitionRx Ltd position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 2,842 VolitionRx Ltd shares in Q1 2026, an estimated $14.5K.
  • Susquehanna International Group first reported a position in VolitionRx Ltd in Q4 2018 and held it in 17 quarters.
  • Susquehanna International Group's VolitionRx Ltd position peaked at $249K in Q1 2021.
  • 31 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.